[Advance in Hematopoietic and Immune Reconstitution of Allogeneic Stem Cell Transplantation]

Overview

Journal Zhonghua Xue Ye Xue Za Zhi

Specialty Hematology

Date 2020 Dec 17

PMID 33333706

Citations 5

Authors

Y Y Huo

A M Pang

T Cheng

Affiliations

Soon will be listed here.

Citing Articles

[Clinical analysis on the impact of pretransplant iron overload on allogeneic hematopoietic stem cell transplantation for patients with acquired severe aplastic anemia in pediatric].

Yan L, Xiong H, Long F, Chen Z, Wang Z, Yang L Zhonghua Xue Ye Xue Za Zhi. 2024; 45(6):586-590.

PMID: 39134491 PMC: 11310813. DOI: 10.3760/cma.j.cn121090-20231214-00310.

[Key microbial monitoring and clinical analysis of bloodstream infections and CRO colonization after hematopoietic stem cell transplantation in hematological patients].

Zhang A, Qian C, Wei R, Jiang S, Fang J, Shi W Zhonghua Xue Ye Xue Za Zhi. 2024; 45(2):134-140.

PMID: 38604789 PMC: 11078680. DOI: 10.3760/cma.j.cn121090-20230731-00040.

Clinical characteristics and mortality risk factors of mixed bacterial infections in hematopoietic stem cell transplantation recipients.

Liu Y, Liu Y, Chen X, Jia Y Front Cell Infect Microbiol. 2023; 13:1223824.

PMID: 37790911 PMC: 10543755. DOI: 10.3389/fcimb.2023.1223824.

Epidemiology, drug resistance analysis and mortality risk factor prediction of gram-negative bacteria infections in patients with allogeneic hematopoietic stem cell transplantation.

Liu Y, Liu Y, Liu Y, Chen X, Jia Y Heliyon. 2023; 9(4):e15285.

PMID: 37101646 PMC: 10123215. DOI: 10.1016/j.heliyon.2023.e15285.

Epidemiology, antimicrobial resistance, and mortality risk factors of carbapenem resistant gram-negative bacteria in hematopoietic stem cell transplantation recipients.

Jia Y, Li Y, Liu Y, Yang Z, Chen X, Liu Y Front Cell Infect Microbiol. 2023; 12:1098856.

PMID: 36710978 PMC: 9880043. DOI: 10.3389/fcimb.2022.1098856.

References

Vasu S, Geyer S, Bingman A, Auletta J, Jaglowski S, Elder P . Granulocyte Colony-Stimulating Factor-Mobilized Allografts Contain Activated Immune Cell Subsets Associated with Risk of Acute and Chronic Graft-versus-Host Disease. Biol Blood Marrow Transplant. 2016; 22(4):658-668. DOI: 10.1016/j.bbmt.2015.12.015. View

Gandy K, Domen J, Aguila H, Weissman I . CD8+TCR+ and CD8+TCR- cells in whole bone marrow facilitate the engraftment of hematopoietic stem cells across allogeneic barriers. Immunity. 1999; 11(5):579-90. DOI: 10.1016/s1074-7613(00)80133-8. View

Han T, Xu L, Liu D, Liu K, Wang F, Wang Y . Recombinant human thrombopoietin promotes platelet engraftment after haploidentical hematopoietic stem cell transplantation: a prospective randomized controlled trial. Ann Hematol. 2014; 94(1):117-28. DOI: 10.1007/s00277-014-2158-1. View

Karpova D, Ritchey J, Holt M, Abou-Ezzi G, Monlish D, Batoon L . Continuous blockade of CXCR4 results in dramatic mobilization and expansion of hematopoietic stem and progenitor cells. Blood. 2017; 129(21):2939-2949. PMC: 5445573. DOI: 10.1182/blood-2016-10-746909. View

Cao T, Shizuru J, Wong R, Sheehan K, Laport G, Stockerl-Goldstein K . Engraftment and survival following reduced-intensity allogeneic peripheral blood hematopoietic cell transplantation is affected by CD8+ T-cell dose. Blood. 2004; 105(6):2300-6. DOI: 10.1182/blood-2004-04-1473. View

Fisher S, Lamikanra A, Doree C, Gration B, Tsang P, Danby R . Increased regulatory T cell graft content is associated with improved outcome in haematopoietic stem cell transplantation: a systematic review. Br J Haematol. 2017; 176(3):448-463. DOI: 10.1111/bjh.14433. View

Pei X, Zhao X, Xu L, Wang Y, Zhang X, Chang Y . Immune reconstitution in patients with acquired severe aplastic anemia after haploidentical stem cell transplantation. Bone Marrow Transplant. 2017; 52(11):1556-1562. DOI: 10.1038/bmt.2017.174. View

Anasetti C, Logan B, Lee S, Waller E, Weisdorf D, Wingard J . Peripheral-blood stem cells versus bone marrow from unrelated donors. N Engl J Med. 2012; 367(16):1487-96. PMC: 3816375. DOI: 10.1056/NEJMoa1203517. View

Cao T, Wong R, Sheehan K, Laport G, Stockerl-Goldstein K, Johnston L . CD34, CD4, and CD8 cell doses do not influence engraftment, graft-versus-host disease, or survival following myeloablative human leukocyte antigen-identical peripheral blood allografting for hematologic malignancies. Exp Hematol. 2005; 33(3):279-85. DOI: 10.1016/j.exphem.2004.12.004. View

10.

de Koning C, Plantinga M, Besseling P, Boelens J, Nierkens S . Immune Reconstitution after Allogeneic Hematopoietic Cell Transplantation in Children. Biol Blood Marrow Transplant. 2015; 22(2):195-206. DOI: 10.1016/j.bbmt.2015.08.028. View

11.

Holtick U, Albrecht M, Chemnitz J, Theurich S, Shimabukuro-Vornhagen A, Skoetz N . Comparison of bone marrow versus peripheral blood allogeneic hematopoietic stem cell transplantation for hematological malignancies in adults - a systematic review and meta-analysis. Crit Rev Oncol Hematol. 2015; 94(2):179-88. DOI: 10.1016/j.critrevonc.2014.12.007. View

12.

DSouza A, Fretham C, Lee S, Arora M, Brunner J, Chhabra S . Current Use of and Trends in Hematopoietic Cell Transplantation in the United States. Biol Blood Marrow Transplant. 2020; 26(8):e177-e182. PMC: 7404814. DOI: 10.1016/j.bbmt.2020.04.013. View

13.

Chaudhry M, Velardi E, Malard F, van den Brink M . Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation: Time To T Up the Thymus. J Immunol. 2016; 198(1):40-46. DOI: 10.4049/jimmunol.1601100. View

14.

Fisher S, Cutler A, Doree C, Brunskill S, Stanworth S, Navarrete C . Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft-versus-host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition. Cochrane Database Syst Rev. 2019; 1:CD009768. PMC: 6353308. DOI: 10.1002/14651858.CD009768.pub2. View

15.

Rezvani A, Storer B, Guthrie K, Schoch H, Maloney D, Sandmaier B . Impact of donor age on outcome after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2014; 21(1):105-12. PMC: 4286386. DOI: 10.1016/j.bbmt.2014.09.021. View

16.

Tobin L, Healy M, English K, Mahon B . Human mesenchymal stem cells suppress donor CD4(+) T cell proliferation and reduce pathology in a humanized mouse model of acute graft-versus-host disease. Clin Exp Immunol. 2013; 172(2):333-48. PMC: 3628335. DOI: 10.1111/cei.12056. View

17.

Kollman C, Spellman S, Zhang M, Hassebroek A, Anasetti C, Antin J . The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy. Blood. 2015; 127(2):260-7. PMC: 4713163. DOI: 10.1182/blood-2015-08-663823. View

18.

Akahoshi Y, Kimura S, Gomyo A, Hayakawa J, Tamaki M, Harada N . Delayed platelet recovery after allogeneic hematopoietic stem cell transplantation: Association with chronic graft-versus-host disease and survival outcome. Hematol Oncol. 2017; 36(1):276-284. DOI: 10.1002/hon.2427. View

19.

Krieger N, Yin D, Fathman C . CD4+ but not CD8+ cells are essential for allorejection. J Exp Med. 1996; 184(5):2013-8. PMC: 2192869. DOI: 10.1084/jem.184.5.2013. View

20.

Aljitawi O, Paul S, Ganguly A, Lin T, Ganguly S, Vielhauer G . Erythropoietin modulation is associated with improved homing and engraftment after umbilical cord blood transplantation. Blood. 2016; 128(25):3000-3010. PMC: 5179334. DOI: 10.1182/blood-2016-05-715292. View